BRPI0806997A2 - Derivado de 4-amino-quinolia, composição farmacêutica, e, uso de um derivado de 4-amino-quinolina ou um sal de adição farmaceuticamente aceitável do mesmo - Google Patents
Derivado de 4-amino-quinolia, composição farmacêutica, e, uso de um derivado de 4-amino-quinolina ou um sal de adição farmaceuticamente aceitável do mesmoInfo
- Publication number
- BRPI0806997A2 BRPI0806997A2 BRPI0806997-2A2A BRPI0806997A BRPI0806997A2 BR PI0806997 A2 BRPI0806997 A2 BR PI0806997A2 BR PI0806997 A BRPI0806997 A BR PI0806997A BR PI0806997 A2 BRPI0806997 A2 BR PI0806997A2
- Authority
- BR
- Brazil
- Prior art keywords
- derivative
- aminokinoly
- aminokinoline
- pharmaceutically acceptable
- pharmaceutical composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 2
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 abstract 1
- 241000224017 Plasmodium berghei Species 0.000 abstract 1
- 241000223960 Plasmodium falciparum Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000000078 anti-malarial effect Effects 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 229960003677 chloroquine Drugs 0.000 abstract 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 abstract 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 abstract 1
- 229960004022 clotrimazole Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200700263 | 2007-02-20 | ||
| PCT/EP2008/051923 WO2008101891A1 (en) | 2007-02-20 | 2008-02-18 | Novel 4-amino-quinoline derivatives useful as anti-malaria drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0806997A2 true BRPI0806997A2 (pt) | 2014-04-15 |
Family
ID=39358301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0806997-2A2A BRPI0806997A2 (pt) | 2007-02-20 | 2008-02-18 | Derivado de 4-amino-quinolia, composição farmacêutica, e, uso de um derivado de 4-amino-quinolina ou um sal de adição farmaceuticamente aceitável do mesmo |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20100093726A1 (pt) |
| EP (1) | EP2121616B1 (pt) |
| AT (1) | ATE481388T1 (pt) |
| BR (1) | BRPI0806997A2 (pt) |
| DE (1) | DE602008002563D1 (pt) |
| WO (1) | WO2008101891A1 (pt) |
-
2008
- 2008-02-18 EP EP08709064A patent/EP2121616B1/en not_active Not-in-force
- 2008-02-18 AT AT08709064T patent/ATE481388T1/de not_active IP Right Cessation
- 2008-02-18 DE DE602008002563T patent/DE602008002563D1/de active Active
- 2008-02-18 BR BRPI0806997-2A2A patent/BRPI0806997A2/pt not_active IP Right Cessation
- 2008-02-18 WO PCT/EP2008/051923 patent/WO2008101891A1/en not_active Ceased
- 2008-02-18 US US12/527,454 patent/US20100093726A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE602008002563D1 (de) | 2010-10-28 |
| US20100093726A1 (en) | 2010-04-15 |
| ATE481388T1 (de) | 2010-10-15 |
| EP2121616B1 (en) | 2010-09-15 |
| WO2008101891A1 (en) | 2008-08-28 |
| EP2121616A1 (en) | 2009-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA32230B1 (fr) | Formes cristallines et deux formes solvatées de lactates de 4-amino-5-fluoro -3-[5-(4-méthylpipérazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one | |
| MX2012003555A (es) | Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma. | |
| Osorio et al. | Alkaloids with antiprotozoal activity | |
| TNSN08326A1 (en) | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
| TW200801000A (en) | Spiroindolinone derivatives | |
| UA96449C2 (en) | Stable laquinimod preparations | |
| BRPI0916356A2 (pt) | ||
| WO2006108405A3 (de) | Nanopartikel-wirkstoff-konjugate | |
| EA017278B9 (ru) | Соединения азаиндазола и способы применения | |
| MX377553B (es) | Composicion farmaceutica estable y metodos de uso de la misma. | |
| TW200833693A (en) | Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors | |
| WO2009111653A3 (en) | Antiviral therapeutic agents | |
| UA96633C2 (uk) | Лікарський засіб, що містить похідне карбостирилу і донепезил, для лікування хвороби альцгеймера | |
| MY149854A (en) | Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
| WO2011025167A3 (ko) | 2, 6-위치가 치환된 3-니트로피리딘 유도체 화합물 또는 이의 약제학적으로 허용 가능한 염을 포함하는 암 예방 또는 치료용 약학 조성물 | |
| Madapa et al. | Search for new pharmacophores for antimalarial activity. Part I: synthesis and antimalarial activity of new 2-methyl-6-ureido-4-quinolinamides | |
| WO2009060952A1 (ja) | 新規製剤 | |
| CL2009001267A1 (es) | Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis. | |
| MX2009004295A (es) | Uso de un acido indazolmetoxialcanoico para reducir niveles de triglicerido, colesterol y glucosa. | |
| PT1981862E (pt) | Compostos relacionados com lantionina para o tratamento de doenças inflamatórias | |
| MA31630B1 (fr) | Dérivés de 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamides et de 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamides, leur préparation et leur application en thérapeutique | |
| MY182553A (en) | Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions | |
| WO2008001294A3 (en) | High dose oral pharmaceutical compositions of artemether and lumefantrine | |
| EA201291114A1 (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-a]ПИРИДИНА | |
| DE602008002563D1 (de) | Neuartige als anti-malaria-wirkstoffe verwendbare 4-amino-chinolinderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 4A E 6A ANUIDADES. |
|
| B08I | Publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 6A, 7A, 8A, 9A, 10A, 11A E 12A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |